Position in LLY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$15,111,048,894
+$2,511,587,837 QoQ
Shares Held
12,598,524
-8.0% QoQ
Ownership
1.34%
of shares outstanding
% of Portfolio
1.05%
of 13F equity value
Holder Rank
#13
of 4,621 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 79%
Shared 0%
None 20%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $61,093,076,744 across 19 Drug Manufacturers - General names. LLY ranks #1 (24.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
12,598,524 | $15,111,048,894 | |
| 2 | JNJ |
Johnson & Johnson
|
58,301,609 | $14,806,859,626 | |
| 3 | ABBV |
AbbVie Inc.
|
47,862,796 | $12,044,193,975 | |
| 4 | MRK |
Merck & Co., Inc.
|
43,886,420 | $5,639,404,964 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
71,713,442 | $4,132,128,518 | |
| 6 | AZN |
Astrazeneca PLC
|
19,204,823 | $3,641,618,528 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
20,820,621 | $2,630,477,247 | |
| 8 | AMGN |
Amgen Inc
|
3,588,484 | $1,299,461,817 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,111,048,894 | 12,598,524 | Shares | Other | 2026-08-12 | |
| 2026-03-31 | $12,599,461,057 | 13,698,491 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $13,968,633,895 | 12,997,946 | Shares | Other | 2026-02-11 | |
| 2025-09-30 | $7,834,602,265 | 10,268,155 | Shares | Other | 2025-11-07 | |
| 2025-06-30 | $9,752,678,775 | 12,510,973 | Shares | Other | 2025-08-12 | |
| 2025-03-31 | $11,133,199,064 | 13,479,918 | Shares | Other | 2025-05-12 | |
| 2024-12-31 | $11,514,179,280 | 14,914,740 | Shares | Other | 2025-02-12 | |
| 2024-09-30 | $16,182,687,225 | 18,266,121 | Shares | Sole | 2024-12-26 | |
| 2024-06-30 | $17,078,659,160 | 18,863,526 | Shares | Other | 2024-12-26 | |
| 2024-03-31 | $14,976,480,720 | 19,250,965 | Shares | Other | 2024-12-26 | |
| 2023-12-31 | $11,310,707,445 | 19,403,533 | Shares | Other | 2024-12-26 | |
| 2023-09-30 | $8,488,368,511 | 15,803,192 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $6,631,196,161 | 14,139,614 | Shares | Other | 2023-08-11 | |
| 2023-03-31 | $3,747,229,038 | 10,911,505 | Shares | Sole | 2023-05-18 | |
| 2022-12-31 | $5,860,632,770 | 16,019,661 | Shares | Other | 2023-02-13 | |
| 2022-09-30 | $4,772,139,949 | 14,758,435 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $5,023,968,159 | 15,495,075 | Shares | Other | 2022-08-11 | |
| 2022-03-31 | $4,666,751,949 | 16,296,232 | Shares | Other | 2022-05-11 | |
| 2021-12-31 | $4,695,153,856 | 16,997,878 | Shares | Other | 2022-02-11 | |
| 2021-09-30 | $3,624,003,993 | 15,684,934 | Shares | Other | 2021-11-12 | |
| 2021-06-30 | $3,934,665,253 | 17,143,017 | Shares | Other | 2021-08-12 | |
| 2021-03-31 | $3,238,117,796 | 17,332,822 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $3,632,870,165 | 21,516,644 | Shares | Other | 2021-02-19 | |
| 2020-09-30 | $2,789,055,738 | 18,842,425 | Shares | Other | 2020-11-12 | |
| 2020-06-30 | $2,617,420,599 | 15,942,384 | Shares | Other | 2020-08-11 | |
| 2020-03-31 | $2,407,653,303 | 17,356,209 | Shares | Other | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||